Reported experiences during syringe purchases in Providence, Rhode Island: Implications for HIV prevention

Journal of Health Care for the Poor and Underserved

Volumn 23, Issue 3, 2012, Pages 1310-1326

  Zaller, Nickolas D ^a   Yokell, Michael A ^b   Apeakorang, Naika ^c   Gaggin, Julia ^d   Case, Patricia ^d  

^a BROWN UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MIRIAM HOSPITAL   (United States)

^d FENWAY INSTITUTE   (United States)

Author keywords

HIV; IDU; Injection drug user; Non prescription syringes; OTC syringes; Pharmacy; Substance abuse

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; FEMALE; HEALTH PERSONNEL ATTITUDE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MALE; MIDDLE AGED; PHARMACIST; PHARMACY; POLICY; SUBSTANCE ABUSE; SYRINGE; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; ATTITUDE OF HEALTH PERSONNEL; FEMALE; HIV INFECTIONS; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; ORGANIZATIONAL POLICY; PHARMACIES; PHARMACISTS; PHARMACISTS' AIDES; RHODE ISLAND; SUBSTANCE ABUSE, INTRAVENOUS; SYRINGES; YOUNG ADULT;

EID: 84864472104     PISSN: 10492089     EISSN: 15486869     Source Type: Journal    
DOI: 10.1353/hpu.2012.0094     Document Type: Article

References (24)

1. Theodorou S, Haber PS. The medical complications of heroin use. Curr Opin Psychiatry. 2005 May;18(3):257-263.
2. Joint United Nations Programme on HIV/AIDS (UNAIDS). Global report: UNAIDS report on the global AIDS epidemic, 2010. Geneva, Switzerland: Joint United NationsProgramme on HIV/AIDS (UNAIDS), 2010. Available at: http://www.unaids.org/globalreport/global_report.htm.
3. Des Jarlais DC. Structural interventions to reduce HIV transmission among injecting drug users. AIDS. 2000 Jun;14 Suppl 1:S41-S46.
4. Des Jarlais D, Perlis T, Arasteh K, et al. HIV incidence among injection drug users in New York City, 1990 to 2002: use of serologic test algorithm to assess expansion of HIV prevention services. Am J Public Health. 2005 Aug;95(8):1439-1444.
5. Gibson DR, Flynn NM, Perales D. Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS. 2001 Jul 27;15(11):1329-1341.
6. National Institutes of Health. Interventions to prevent HIV risk behaviors: National Institutes of Health consensus statement online. Bethesda, MD: National Institutes of Health, 1997. Available at: http://consensus.nih.gov/1997/1997PreventHIVRisk104html.htm.
7. Mathers BM, Degenhardt L, Ali H, et al. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet. 2010 Mar 20;375(9719):1014-1028.
8. Temple University Beasley School of Law. The project on harm reduction in the health care system. Phildelphia, PA: Temple University Beasley School of Law, 2011. Available at: http://www.temple.edu/lawschool/phrhcs/phrhcs.htm.
9. State of Rhode Island and Providence Plantations, Department of Health. Rules and regulations governing hypodermic needles, syringes, and other such instruments (R21-28-CS-4). Providence, RI: State of Rhode Island Department of Health, 2002. Available at: http://sos.ri.gov/documents/archives/regdocs/released/pdf/DOH/DOH_163_.pdf.
10. Zaller ND, Yokell MA, Jeronimo A, et al. Adverse event associated with a change in nonprescription syringe sale policy. J Am Pharm Assoc (2003). 2010 Sep-Oct;50(5):619-622.
11. Deibert RJ, Goldbaum G, Parker TR, et al. Increased access to unrestricted pharmacy sales of syringes in Seattle-King County, Washington: structural and individual-level changes, 1996 versus 2003. Am J Public Health. 2006 Aug;96(8):1347-1353.
12. Rich JD, Martin EG, Macalino GE, et al. Pharmacist support for selling syringes without a prescription to injection drug users in Rhode Island. J Am Pharm Assoc (Wash). 2002 Nov-Dec;42(6 Suppl 2):S58-S61.
13. Rose VJ, Raymond HF. Evaluation of nonprescription syringe sales in San Francisco. J Am Pharm Assoc (2003). 2010 Sep-Oct;50(5):595-599.
14. Coffin PO, Ahern J, Dorris S, et al. More pharmacists in high-risk neighborhoods of New York City support selling syringes to injection drug users. J Am Pharm Assoc (Wash). 2002 Nov-Dec;42(6 Suppl 2):S62-A67.
15. Cooper EN, Dodson C, Stopka TJ, et al. Pharmacy participation in non-prescription syringe sales in Los Angeles and San Francisco counties, 2007. J Urban Health. 2010 Jul; 87(4):543-552.
16. Reich W, Compton WM, Horton JC, et al. Pharmacist ambivalence about sale of syringes to injection drug users. J Am Pharm Assoc. 2002 Nov-Dec;42(6 Suppl 2): S52-S57.
17. Tesoriero JM, Battles HB, Klein SJ, et al. Expanding access to sterile syringes through pharmacies: assessment of New York's Expanded Syringe Access Program. J Am Pharm Assoc (2003). 2009 May-Jun;49(3):407-416.
18. Fuller CM, Galea S, Blaney S, et al. Explaining the relationship between race/ethnicity and pharmacy purchased syringes among injection drug users in New York City. Ethn Dis. 2004 Autumn;14(4):589-596.
19. Rose VJ, Backes G, Martinez S, et al. Non-prescription syringe sales in California: a qualitative examination of practices among 12 local health jurisdictions. J Urban Health. 2010 Jul;87(4):561-575.
20. Zaller N, Jeronimo A, Bratberg J, et al. Pharmacist and pharmacy staff experiences with non-prescription (NP) sale of syringes and attitudes toward providing HIV prevention services for injection drug users (IDUs) in Providence, RI. J Urban Health. 2010 Dec;87(6):942-953.
21. Christensen DB, Farris KB. Pharmaceutical care in community pharmacies: practice and research in the U.S. Ann Pharmacother. 2006 Jul-Aug;40(7/8):1400-1406.
22. Rivera AV, Blaney S, Crawford ND, et al. Individual- and neighborhood-level factors associated with nonprescription counseling in pharmacies participating in the New York State Expanded Syringe Access Program. J Am Pharm Assoc (2003). 2010 Sep-Oct;50(5):580-587.
23. Rudolph AE, Standish K, Amesty S, et al. A community-based approach to linking injection drug users with needed services through pharmacies: an evaluation of a pilot intervention in New York City. AIDS Educ Prev. 2010 Jun;22(3):238-251.
24. Caranci PF, Farmanian R, Goldman D, et al. Eureka-implementing safe community needle disposal in Rhode Island. J Am Pharm Assoc (Wash). 2002 Nov-Dec;42(6 Suppl 2):S109-A110.